Tolerogenic nanoparticles suppress central nervous system inflammation

Jessica E. Kenison,Aditi Jhaveri,Zhaorong Li,Nikita Khadse,Emily C. Tjon,S. Tezza,D. Nowakowska,A. Plasencia,V. Stanton,D. Sherr,F. Quintana

DOI: https://doi.org/10.1073/pnas.2016451117

2020-11-25

Abstract:Significance Current treatments for autoimmune diseases rely on nonspecific immunosuppression, risking important complications and limiting the long-term use of these approaches for the treatment of chronic human autoimmunity. Thus, there is an unmet need for therapeutic approaches to reestablish immune tolerance in autoimmune disorders in an antigen-specific manner. Here, we describe a nanoliposome (NLP)-based platform for the induction of antigen-specific tolerance via the modulation of signaling by the aryl hydrocarbon receptor. These NLPs suppress disease pathology and pathogenic autoimmunity in preclinical models of multiple sclerosis, providing a candidate antigen-specific therapeutic approach for the management of autoimmune disorders. Therapeutic approaches for the induction of immune tolerance remain an unmet clinical need for the treatment of autoimmune diseases, including multiple sclerosis (MS). Based on its role in the control of the immune response, the ligand-activated transcription factor aryl hydrocarbon receptor (AhR) is a candidate target for novel immunotherapies. Here, we report the development of AhR-activating nanoliposomes (NLPs) to induce antigen-specific tolerance. NLPs loaded with the AhR agonist ITE and a T cell epitope from myelin oligodendrocyte glycoprotein (MOG)35–55 induced tolerogenic dendritic cells and suppressed the development of experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS, in preventive and therapeutic setups. EAE suppression was associated with the expansion of MOG35–55-specific FoxP3+ regulatory T cells (Treg cells) and type 1 regulatory T cells (Tr1 cells), concomitant with a reduction in central nervous system-infiltrating effector T cells (Teff cells). Notably, NLPs induced bystander suppression in the EAE model established in C57BL/6 × SJL F1 mice. Moreover, NLPs ameliorated chronic progressive EAE in nonobese diabetic mice, a model which resembles some aspects of secondary progressive MS. In summary, these studies describe a platform for the therapeutic induction of antigen-specific tolerance in autoimmune diseases.

Medicine